Literature DB >> 20422499

Organic solute transporter, OSTalpha-OSTbeta: its role in bile acid transport and cholestasis.

Carol J Soroka1, Nazzareno Ballatori, James L Boyer.   

Abstract

Organic solute transporter alpha-beta (OSTalpha-OSTbeta) is a unique heteromeric transporter localized to the basolateral membrane of epithelial cells involved in sterol transport. It is believed to be the primary bile acid efflux transporter in the intestine of mammals and is therefore essential to bile acid homeostasis and the enterohepatic circulation. First described in the evolutionarily primitive small skate, LEUCORAJA ERINACEA, this facilitated transporter requires expression of both subunits for its function. It can transport a variety of bile acids, as well as estrone 3-sulfate, dehydroepiandrosterone 3-sulfate, digoxin, and prostaglandin E (2). Expression of both subunits is variable between species and tissues; in humans high expression is noted in the liver, small intestine, kidney, testis, and adrenal gland. OSTalpha-OSTbeta is directly regulated by the bile acid sensing nuclear receptor, farnesoid X receptor (FXR). Furthermore, it is part of the complex regulatory pathway that controls bile acid synthesis and homeostasis. Hepatic OSTalpha-OSTbeta is upregulated in cholestasis in both humans and rodents, where it appears to play a protective role. Additional studies are necessary to determine its role in liver injury, bile acid malabsorption, and lipid and glucose metabolism, as well as a potential protective role for kidney OSTalpha-OSTbeta in cholestasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20422499      PMCID: PMC3713633          DOI: 10.1055/s-0030-1253226

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  60 in total

1.  The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp.

Authors:  L A Denson; E Sturm; W Echevarria; T L Zimmerman; M Makishima; D J Mangelsdorf; S J Karpen
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

2.  Analysis of the in vivo functions of Mrp3.

Authors:  Martin G Belinsky; Paul A Dawson; Irina Shchaveleva; Lisa J Bain; Renxue Wang; Victor Ling; Zhe-Sheng Chen; Alex Grinberg; Heiner Westphal; Andres Klein-Szanto; Anthony Lerro; Gary D Kruh
Journal:  Mol Pharmacol       Date:  2005-04-06       Impact factor: 4.436

3.  ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3).

Authors:  T Hirohashi; H Suzuki; H Takikawa; Y Sugiyama
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

4.  FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine.

Authors:  Hans Lee; Yanqiao Zhang; Florence Y Lee; Stanley F Nelson; Frank J Gonzalez; Peter A Edwards
Journal:  J Lipid Res       Date:  2005-10-26       Impact factor: 5.922

5.  Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.

Authors:  Takeshi Inagaki; Mihwa Choi; Antonio Moschetta; Li Peng; Carolyn L Cummins; Jeffrey G McDonald; Guizhen Luo; Stacey A Jones; Bryan Goodwin; James A Richardson; Robert D Gerard; Joyce J Repa; David J Mangelsdorf; Steven A Kliewer
Journal:  Cell Metab       Date:  2005-10       Impact factor: 27.287

6.  The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes.

Authors:  Jean-François Landrier; Jyrki J Eloranta; Stephan R Vavricka; Gerd A Kullak-Ublick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-11-03       Impact factor: 4.052

7.  OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia.

Authors:  Nazzareno Ballatori; Whitney V Christian; Jin Young Lee; Paul A Dawson; Carol J Soroka; James L Boyer; Michael S Madejczyk; Na Li
Journal:  Hepatology       Date:  2005-12       Impact factor: 17.425

8.  Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

Authors:  C J Sinal; M Tohkin; M Miyata; J M Ward; G Lambert; F J Gonzalez
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

9.  Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.

Authors:  T T Lu; M Makishima; J J Repa; K Schoonjans; T A Kerr; J Auwerx; D J Mangelsdorf
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

10.  Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver.

Authors:  C J Soroka; J M Lee; F Azzaroli; J L Boyer
Journal:  Hepatology       Date:  2001-04       Impact factor: 17.425

View more
  27 in total

1.  β-Subunit of the Ostα-Ostβ organic solute transporter is required not only for heterodimerization and trafficking but also for function.

Authors:  Whitney V Christian; Na Li; Patricia M Hinkle; Nazzareno Ballatori
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

Review 2.  Bile acid transporter-mediated oral drug delivery.

Authors:  Feiyang Deng; You Han Bae
Journal:  J Control Release       Date:  2020-07-22       Impact factor: 9.776

Review 3.  The role of inflammation in cholestasis: clinical and basic aspects.

Authors:  Astrid Kosters; Saul J Karpen
Journal:  Semin Liver Dis       Date:  2010-04-26       Impact factor: 6.115

4.  SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes.

Authors:  Natarajan Balasubramaniyan; Yuhuan Luo; An-Qiang Sun; Frederick J Suchy
Journal:  J Biol Chem       Date:  2013-04-01       Impact factor: 5.157

5.  Differential disposition of chenodeoxycholic acid versus taurocholic acid in response to acute troglitazone exposure in rat hepatocytes.

Authors:  Tracy L Marion; Cassandra H Perry; Robert L St Claire; Wei Yue; Kim L R Brouwer
Journal:  Toxicol Sci       Date:  2011-01-24       Impact factor: 4.849

6.  Nuclear factor-κB regulates the expression of multiple genes encoding liver transport proteins.

Authors:  Natarajan Balasubramaniyan; Meenakshisundaram Ananthanarayanan; Frederick J Suchy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-02-11       Impact factor: 4.052

7.  Mechanism underlying an elevated serum bile acid level in chronic renal failure patients.

Authors:  Lei Chu; Kangkang Zhang; Yingying Zhang; Xunbo Jin; Huaxin Jiang
Journal:  Int Urol Nephrol       Date:  2014-12-25       Impact factor: 2.370

8.  Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents.

Authors:  Dongke Yu; Shi-Ying Cai; Albert Mennone; Pamela Vig; James L Boyer
Journal:  Liver Int       Date:  2018-02-13       Impact factor: 5.828

Review 9.  Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.

Authors:  James J Beaudoin; Kim L R Brouwer; Melina M Malinen
Journal:  Pharmacol Ther       Date:  2020-04-02       Impact factor: 12.310

Review 10.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.